Late Morbidity After Successful Treatment of Children with Cancer
Authors:
- Smita BhatiaSBSmita Bhatia
- Louis S. ConstineLCLouis S. Constine
- 1 May 2009
- journal article
- review article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 15 (3) , 174-180
Abstract
Over the last 4 decades, there has been a tremendous improvement in survival of children diagnosed with cancer, with 5-year survival rates now averaging 80%. The rapidly growing population of childhood cancer survivors creates an obligation to understand the health and well being of these individuals. Use of cancer therapy at an early age can produce a large burden of morbidity, as demonstrated quite conclusively by the fact that approximately two thirds of these survivors will experience at least one late effect, and approximately one third will experience a late effect, that is, severe or life threatening. Long-term complications in childhood cancer survivors, such as impairment in growth and development, neurocognitive dysfunction, cardiopulmonary compromise, endocrine dysfunction, renal impairment, gastrointestinal dysfunction, musculoskeletal sequelae, and second cancers, are related not only to the specific therapy used, but may also be determined by individual host characteristics. This review provides an update of the known late effects observed in childhood cancer survivors to provide the rationale for evaluation of specific long-term problems in this growing population of individuals at risk for chronic health conditions.Keywords
This publication has 56 references indexed in Scilit:
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor StudyJNCI: Journal of the National Cancer Institute, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006
- Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control studyThe Lancet, 2005
- Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing DisciplineJournal of Clinical Oncology, 2004
- High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study GroupJournal of Clinical Oncology, 2003
- Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor StudyJNCI: Journal of the National Cancer Institute, 2001
- Cancer Incidence After RetinoblastomaJAMA, 1997
- Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's DiseaseNew England Journal of Medicine, 1996
- Radiotherapy, Alkylating Agents, and Risk of Bone Cancer After Childhood CancerJNCI: Journal of the National Cancer Institute, 1996